Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 245

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 245
---
 balance as of December 31, 2024 and 2023 is $ 155,891and $ 159,023, respectively. The current maturity at December 31, 2024 is $ 8,772and the long-term liability is $ 147,119($ 8,772and $ 150,251at December 31, 2023, respectively). The loan is collateralized by all tangible and intangible personal property of the Company. The Company is prohibited from accepting future advances under any superior liens on the collateral without the prior consent of SBA.

The current future payment obligations of the principal are as follows:

| Period     |     | Principal 
 Payments  |         |
|:-----------|:----|:----------|--------:|
| 2025       |     | $         |       - |
| 2026       |     |           |     404 |
| 2027       |     |           |   3,217 |
| 2028       |     |           |   3,332 |
| 2029       |     |           |   3,467 |
| Thereafter |     |           | 139,580 |
| Total      |     | $         | 150,000 |

F-27 Related Party Advances In March 2023, the Company received a $ 200,000short term advance from the Geoffrey S. Dow Revocable Trust. In April 2023, the Company received $ 50,000as a short-term advance from management. The Geoffrey S. Dow Revocable Trust contributed $ 23,000and Tyrone Miller contributed $ 27,000. On May 11, 2023, these short term advances were refunded in full for an aggregate amount of $ 250,000.

8. DERIVATIVE LIABILITIES

In accordance with the provisions of ASC 815, derivative liabilities are initially measured at fair value at the commitment date and subsequently remeasured at each reporting period, with any increase or decrease in the fair value recorded in the results of operations within other income/expense as the change in fair value of derivative liabilities.

As discussed in Notes 6 and 7 above, certain of the Company’s bridge shares, warrants and convertible notes (containing an embedded conversion feature) were previously accounted for as derivative liabilities. The bridge shares and related conversion features were derecognized upon conversion of the related debt obligations on the date of the IPO. In addition, certain